当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析 - 资产负债表

益佰制药

(600594)

  

流通市值:29.02亿  总市值:29.02亿
流通股本:7.84亿   总股本:7.84亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金430,232,548.1489,897,047.83447,132,630.97593,695,601.81
  应收票据及应收账款285,615,069.38327,342,398.14376,974,397.68378,549,822.5
  其中:应收票据156,511,470.99197,334,336.27209,636,740.01204,412,969.62
        应收账款129,103,598.39130,008,061.87167,337,657.67174,136,852.88
  预付款项10,484,227.8411,439,008.48,533,498.6923,647,927.94
  其他应收款合计36,314,341.437,923,837.8731,882,798.4230,798,884.22
  其中:应收利息---32,591.03
  存货526,337,438.21540,242,201.26546,902,616.32545,495,239.8
  一年内到期的非流动资产1,837,512.191,739,237.01--
  其他流动资产54,250,560.4534,495,593.6436,291,808.2857,820,739.42
  流动资产合计1,345,071,697.571,443,079,324.151,447,717,750.361,630,008,215.69
非流动资产:
  长期应收款6,044,416.286,488,883.11--
  长期股权投资34,608,114.4234,682,969.4534,802,100.7634,703,753.79
  其他权益工具投资1,103,201.641,093,940.441,093,625.971,290,618.61
  固定资产1,386,407,006.681,405,959,477.211,445,207,657.591,476,529,492.01
  在建工程3,598,714.232,745,604.412,180,557.226,303,210.37
  生产性生物资产24,398,934.5924,224,255.7419,594,943.1116,597,724.12
  使用权资产4,469,332.785,627,964.197,126,500.7923,904,263.2
  无形资产304,775,564.99308,259,414.67312,294,392.62309,700,848.79
  商誉---131,262,741.12
  长期待摊费用68,722,257.473,089,685.6677,821,638.6189,959,878.83
  递延所得税资产79,549,910.4976,137,290.8677,813,654.72100,701,036.12
  其他非流动资产8,211,843.1816,837,396.9316,182,841.0117,226,738.93
  非流动资产合计1,921,889,296.681,955,146,882.671,994,117,912.42,208,180,305.89
  资产总计3,266,960,994.253,398,226,206.823,441,835,662.763,838,188,521.58
流动负债:
  短期借款413,855,915.41438,870,292.26413,928,393.94413,894,610.61
  应付票据及应付账款67,084,313.8182,595,022.99102,985,998.7791,684,492.89
        应付账款67,084,313.8182,595,022.99102,985,998.7791,684,492.89
  合同负债20,504,188.9925,548,095.8124,278,195.2721,012,907.93
  应付职工薪酬31,006,388.7227,704,404.5945,505,503.5135,953,417.1
  应交税费14,651,791.0621,141,307.417,690,297.9924,368,447.87
  其他应付款合计118,458,309.58127,045,706.33114,789,710.5478,635,196.16
  其中:应付利息171,203.52171,203.52171,203.52171,203.52
  一年内到期的非流动负债124,921,914.73123,806,918.89188,168,033.53202,011,659.75
  其他流动负债1,346,176.941,239,122.661,529,319.41875,995.47
  流动负债合计791,828,999.24847,950,870.93908,875,452.96868,436,727.78
非流动负债:
  长期借款149,539,169.12150,189,169.13100,139,169.12229,558,002.95
  租赁负债116,891.862,278,920.072,359,153.820,650,392.79
  长期应付款17,000,00037,000,00037,555,00080,000,000
  预计负债1,759,009.652,162,632.072,201,492.0759,497.51
  递延收益83,639,920.4985,568,521.4388,165,024.0190,776,664.05
  递延所得税负债30,926,426.5931,435,169.9431,936,395.3633,243,435.44
  非流动负债合计282,981,417.71308,634,412.64262,356,234.36454,287,992.74
  负债合计1,074,810,416.951,156,585,283.571,171,231,687.321,322,724,720.52
所有者权益(或股东权益):
  实收资本(或股本)791,927,400791,927,400791,927,400791,927,400
  资本公积681,591,861.64681,591,861.64681,591,861.64653,836,676.92
  减:库存股25,004,481.1425,004,481.1425,004,481.1425,004,481.14
  其他综合收益289,006.69282,060.79281,824.94429,569.42
  盈余公积314,569,579.33314,569,579.33314,569,579.33314,569,579.33
  未分配利润344,082,876.49394,895,786.7424,420,689.59667,420,393.75
  归属于母公司股东权益合计2,107,456,243.012,158,262,207.322,187,786,874.362,403,179,138.28
  少数股东权益84,694,334.2983,378,715.9382,817,101.08112,284,662.78
  股东权益合计2,192,150,577.32,241,640,923.252,270,603,975.442,515,463,801.06
  负债和股东权益合计3,266,960,994.253,398,226,206.823,441,835,662.763,838,188,521.58
公告日期2026-08-212026-04-232026-04-232025-10-30
审计意见(境内)标准无保留意见
TOP↑